Project Details
Description
CRISPR/Cas9 Cellular Engineering for the Creation of Coagulation Factor-Based Resuscitation Fluid to Combat Hemorrhage and Coagulopathy
| Status | Active |
|---|---|
| Effective start/end date | 6/16/20 → 6/15/23 |
Funding
- THE GENEVA FOUNDATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.